Wall Street analysts predict that Acadia Healthcare Company, Inc. (NASDAQ:ACHC) will report sales of $729.80 million for the current fiscal quarter, Zacks reports. Seven analysts have made estimates for Acadia Healthcare’s earnings, with the highest sales estimate coming in at $738.60 million and the lowest estimate coming in at $721.50 million. Acadia Healthcare reported sales of $734.67 million in the same quarter last year, which indicates a negative year-over-year growth rate of 0.7%. The business is scheduled to announce its next quarterly earnings results on Tuesday, November 7th.

According to Zacks, analysts expect that Acadia Healthcare will report full year sales of $729.80 million for the current year, with estimates ranging from $2.84 billion to $2.89 billion. For the next fiscal year, analysts expect that the firm will post sales of $3.09 billion per share, with estimates ranging from $3.04 billion to $3.12 billion. Zacks’ sales averages are an average based on a survey of research firms that that provide coverage for Acadia Healthcare.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Thursday, July 27th. The company reported $0.66 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.65 by $0.01. The firm had revenue of $715.90 million during the quarter, compared to analyst estimates of $717.38 million. Acadia Healthcare had a net margin of 0.30% and a return on equity of 8.69%. Acadia Healthcare’s revenue was down 5.4% on a year-over-year basis. During the same period last year, the firm posted $0.73 EPS.

A number of equities research analysts have weighed in on ACHC shares. Deutsche Bank AG boosted their price objective on Acadia Healthcare from $58.00 to $60.00 and gave the company a “buy” rating in a research note on Monday, July 31st. Craig Hallum restated a “buy” rating and set a $65.00 price target (up previously from $52.00) on shares of Acadia Healthcare in a research note on Monday, July 31st. Mizuho upped their price target on Acadia Healthcare from $57.00 to $60.00 and gave the stock a “buy” rating in a research note on Friday, July 28th. BidaskClub raised Acadia Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, July 1st. Finally, Zacks Investment Research raised Acadia Healthcare from a “hold” rating to a “buy” rating and set a $53.00 price objective on the stock in a report on Wednesday, June 28th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company’s stock. Acadia Healthcare presently has an average rating of “Buy” and an average target price of $58.69.

Shares of Acadia Healthcare (NASDAQ:ACHC) traded down 4.06% during trading on Friday, hitting $46.78. 1,814,213 shares of the company traded hands. Acadia Healthcare has a 52-week low of $32.54 and a 52-week high of $54.34. The company has a 50-day moving average of $48.96 and a 200-day moving average of $45.91. The stock has a market capitalization of $4.11 billion, a PE ratio of 514.07 and a beta of 1.14.

In other Acadia Healthcare news, CEO Joey A. Jacobs sold 500,000 shares of the business’s stock in a transaction dated Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total value of $25,345,000.00. Following the transaction, the chief executive officer now owns 201,496 shares in the company, valued at $10,213,832.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Reeve B. Waud sold 50,000 shares of the business’s stock in a transaction dated Thursday, June 22nd. The shares were sold at an average price of $47.51, for a total value of $2,375,500.00. The disclosure for this sale can be found here. Insiders have sold a total of 3,185,693 shares of company stock worth $162,606,599 in the last ninety days. 11.10% of the stock is owned by company insiders.

Several large investors have recently made changes to their positions in the business. Davidson Kempner Capital Management LP lifted its position in shares of Acadia Healthcare by 16.7% in the second quarter. Davidson Kempner Capital Management LP now owns 350,000 shares of the company’s stock worth $17,283,000 after buying an additional 50,000 shares during the last quarter. Public Employees Retirement System of Ohio lifted its position in shares of Acadia Healthcare by 10.9% during the 2nd quarter. Public Employees Retirement System of Ohio now owns 81,729 shares of the company’s stock worth $4,036,000 after purchasing an additional 8,066 shares during the last quarter. Asymmetry Capital Management L.P. lifted its position in shares of Acadia Healthcare by 594.0% during the 2nd quarter. Asymmetry Capital Management L.P. now owns 82,694 shares of the company’s stock worth $4,083,000 after purchasing an additional 70,779 shares during the last quarter. Ameritas Investment Partners Inc. acquired a new position in shares of Acadia Healthcare during the 2nd quarter worth about $1,129,000. Finally, Raymond James Financial Services Advisors Inc. lifted its position in shares of Acadia Healthcare by 346.0% during the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 34,757 shares of the company’s stock worth $1,716,000 after purchasing an additional 26,964 shares during the last quarter.

ILLEGAL ACTIVITY WARNING: “$729.80 Million in Sales Expected for Acadia Healthcare Company, Inc. (ACHC) This Quarter” was first reported by American Banking News and is owned by of American Banking News. If you are accessing this report on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/09/16/729-80-million-in-sales-expected-for-acadia-healthcare-company-inc-achc-this-quarter.html.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Get a free copy of the Zacks research report on Acadia Healthcare (ACHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.